1. Academic Validation
  2. Enhancement of the cytotoxic effect of dihydroartemisinin in high-risk human papillomavirus-infected cells by aminolevulinic acid via the Bax/Bcl-2-caspase pathway

Enhancement of the cytotoxic effect of dihydroartemisinin in high-risk human papillomavirus-infected cells by aminolevulinic acid via the Bax/Bcl-2-caspase pathway

  • Photodiagnosis Photodyn Ther. 2022 Aug 3;40:103053. doi: 10.1016/j.pdpdt.2022.103053.
Qilei Che 1 Qi Wang 2 Hongyan Lu 2 Changxing Li 3 Kang Zeng 4
Affiliations

Affiliations

  • 1 Department of Dermatology and Venereology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Department of Medical Cosmetology, Chengdu Second People's Hospital, Chengdu 610031,China.
  • 2 Department of Dermatology and Venereology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
  • 3 Department of Dermatology and Venereology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. Electronic address: lilichangxing@163.com.
  • 4 Department of Dermatology and Venereology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. Electronic address: nfpfkzk@126.com.
Abstract

Background: Traditional treatments for human papillomavirus-related cutaneous diseases include 5-aminolevulinic acid photodynamic therapy, cryotherapy, microwave ablation, and surgical resection. These treatment methods involvevarious adverse reactions; therefore, it remains necessary to explore new treatment methods. Dihydroartemisinin shows cytotoxic effects against several malignancies by producing Reactive Oxygen Species, and heme environments reportedly enhance its activity. However, the underlying mechanismsare still unclear. Therefore, we investigated the mechanism of dihydroartemisininin inhuman papillomavirus-infected cells.

Methods: HeLa cells were treated with dihydroartemisinin, 5-aminolevulinic acid, and succinylacetone. The cell viability, Apoptosis, mitochondrial membrane potential, and Reactive Oxygen Species levels were investigated, and via western blotting analysis and polymerase chain reaction, dihydroartemisinin activity-related pathways were also determined.

Results: Dihydroartemisinin inhibited HeLa cell proliferation and promoted cell Apoptosis via the Bax/Bcl-2-Caspase pathway in a concentration-dependent manner. The specific cytotoxicity toward HeLa cells was enhanced by the addition of 5-aminolevulinic acid, a clinically used heme-synthesis precursor, owing to an increase in heme levels. Conversely, following the addition of succinylacetone, a heme synthesis blocker, heme levels decreased. Furthermore, dihydroartemisinin significantly increased Reactive Oxygen Species levels as intracellular heme synthesis increased. Moreover, photodynamic therapy following dihydroartemisinin and 5-aminolevulinic acid treatment further enhanced the cytotoxic effect of dihydroartemisinin on high-risk human papillomavirus-infected cells.

Conclusions: Dihydroartemisinin exerts acytotoxic effect on high-risk human papillomavirus-infected cells by modulating heme levels via the Bax/Bcl-2-Caspase pathway, and the dihydroartemisinin, 5-aminolevulinic acid, photodynamic therapy combination treatment significantly enhanced its cytotoxic effect on human papillomavirus-infected cells.

Keywords

5-aminolevulinic acid; Cytotoxicity; Dihydroartemisinin; Human papillomavirus-infected cells; Photodynamic therapy.

Figures
Products